Affiliation:
1. Immunohematology and Transfusion Medicine Hospital Papa Giovanni XXIII Bergamo Italy
Abstract
Postacute COVID‐19 sequelae affect millions of individuals, and active research into the pathophysiological mechanisms and potential treatments is underway. The report by Nara and colleagues shows persistent platelet hyperactivity in the chronic phase of the infection, suggesting a possible role of platelets in post‐COVID‐19 complications and, consequently, a possible therapeutic target.Commentary on: Nara et al. Prolonged platelet hyperactivity after COVID‐19 infection. Br J Haematol 2023 (Online ahead of print) doi: 10.1111/bjh.19125.